treatment for covid-19สมัครสมาชิกสล็อตUsing plasma from the blood of a patient with a new strain of corona virus that has been cured. It should not be used on infected people with mild or moderate symptoms. Based on recommendations from the World Health Organization (WHO) on Tuesday (December 7), and even to those with severe symptoms. It should only be used in clinical trials.
r0;Convalescent Plasmar1; (Convalescent Plasma) or plasma from the blood with immune proteins. Shows good signs in the beginning. Times of plasma transfusions for COVID-19 patients
However, in a recommendation published in the British Medical Journal, the World Health Organization states that r0;Current evidence shows that it does not improve survival or reduce the need for mechanical ventilation. costly and takes a long time to maintain"
World Health Organization "Strong recommendation" opposes the use of blood plasma in people who have not been diagnosed with severe COVID-19, and said that even in severe and emergency patients This remedy should only be used as part of a clinical trial.
Convalescent plasma, liquid portion of blood from COVID-19 patients. cured These contain antibodies that the body produces after contracting the new coronavirus.
It was one of the many treatments that were used and considered feasible early on. of the pandemic But clinical trials have shown that its benefits are limited.
The World Health Organization states that Their latest recommendation is based on 16 clinical trials, including patients with COVID-19. both mild symptoms Violence and crisis, a total of 16,236 people.
Portal
